melanoma drug extends life in second large study
people with advanced melanoma who were treated with bristol-myers squibb co's yervoy plus chemotherapy lived an average of two months longer than people who got chemotherapy alone, in the first of many combination studies slated for this promising new drug.
http://feeds.reuters.com/~r/reuters/healthnews/~3/n49ju10tmja/us-cancer-melanoma-bristol-meyers-idustre7541eu20110605
11591
05 Jun 2011 15:50:29
reuters
health